DSM and Phynova reach agreement for global distribution of Reducose®, a science-backed natural ingredient for healthy blood glucose levels
DSM and Phynova have signed a global distribution and collaboration agreement for Reducose®, a patented, natural ingredient for healthy blood glucose levels. Reducose® is backed by several clinical studies and it has regulatory approvals in multiple regions across the world.
Phynova CEO, Mr Robert Miller says: “We are delighted to work with DSM, the leading global health and nutrition ingredient specialist. Along with the distribution and sales of Reducose® we will collaborate closely with them on product development, clinical research, regulatory approvals and marketing.”
Ivo Lansbergen, VP Global Strategic Marketing, DSM Human Nutrition and Health says: “Phynova is a strategic partner for DSM to provide the right nutritional solutions to address the ever-growing health concerns linked to maintaining healthy blood glucose. The combined strengths of DSM and Phynova provide an excellent platform for addressing this major societal challenge.”
Reducose® is a water extract of white mulberry leaves (Morus alba), a plant that has been used for centuries around the world as a food and animal feed. Reducose® can be added in small quantities to foods and drinks or taken as a small supplement. It reduces the impact of high-glycaemic sugars, as well as other carbohydrates, on the body. It does this by reducing the absorption of sugars and other carbohydrates by up to 40%. Reducose® is patent protected and has undergone rigorous safety and efficacy testing.
Diabetes is a rapidly growing health issue with an estimated 425 million adults affected globally. The incidence of prediabetes is even higher with an estimated 390 million prediabetic adults in China alone. Two trends are converging with these increasing numbers and the related healthcare costs: governments are actively working to increase consumer awareness about healthy nutrition and reduction of high-glycaemic foods, and secondly, there is a new generation of non-invasive wearable devices coming to the market that will be able to continuously monitor and make people aware of their blood glucose status.
ENDS
DSM – Bright Science. Brighter Living.™
Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living. DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative business solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
About Phynova
Phynova is an innovative British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants. Founded in 2002, Phynova is based near Oxford, UK with a subsidiary research company located in Beijing, China. Phynova identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops and commercialises solutions for global health concerns.
For more information:
DSM
Ivo Lansbergen
[email protected]
Phynova
Wouter Claerhout
[email protected]
